Researchers clustered 277 cell lines and revealed distinct COVID-19 transcriptomic signatures of the cells with similar phenotypes that defines their suitability for COVID-19 research.
[Scientific Reports]
7753456
{7753456:UKP3ZNE3}
apa
50
1
162695
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-8795456b3e169d85116570e86bb13de2%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22UKP3ZNE3%22%2C%22library%22%3A%7B%22id%22%3A7753456%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Vagapova%20et%20al.%22%2C%22parsedDate%22%3A%222021-05-27%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EVagapova%2C%20E.%20R.%2C%20Lebedev%2C%20T.%20D.%2C%20%26amp%3B%20Prassolov%2C%20V.%20S.%20%282021%29.%20Viral%20fibrotic%20scoring%20and%20drug%20screen%20based%20on%20MAPK%20activity%20uncovers%20EGFR%20as%20a%20key%20regulator%20of%20COVID-19%20fibrosis.%20%3Ci%3EScientific%20Reports%3C%5C%2Fi%3E%2C%20%3Ci%3E11%3C%5C%2Fi%3E%281%29%2C%2011234.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-021-90701-w%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-021-90701-w%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D7753456%26amp%3Bitem_key%3DUKP3ZNE3%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Viral%20fibrotic%20scoring%20and%20drug%20screen%20based%20on%20MAPK%20activity%20uncovers%20EGFR%20as%20a%20key%20regulator%20of%20COVID-19%20fibrosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elmira%20R.%22%2C%22lastName%22%3A%22Vagapova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timofey%20D.%22%2C%22lastName%22%3A%22Lebedev%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vladimir%20S.%22%2C%22lastName%22%3A%22Prassolov%22%7D%5D%2C%22abstractNote%22%3A%22Understanding%20the%20molecular%20basis%20of%20fibrosis%2C%20the%20lethal%20complication%20of%20COVID-19%2C%20is%20urgent.%20By%20the%20analysis%20of%20RNA-sequencing%20data%20of%20SARS-CoV-2-infected%20cells%20combined%20with%20data%20mining%20we%20identified%20genes%20involved%20in%20COVID-19%20progression.%20To%20characterize%20their%20implication%20in%20the%20fibrosis%20development%20we%20established%20a%20correlation%20matrix%20based%20on%20the%20transcriptomic%20data%20of%20patients%20with%20idiopathic%20pulmonary%20fibrosis.%20With%20this%20method%2C%20we%20have%20identified%20a%20cluster%20of%20genes%20responsible%20for%20SARS-CoV-2-fibrosis%20including%20its%20entry%20receptor%20ACE2%20and%20epidermal%20growth%20factor%20EGF.%20Then%2C%20we%20developed%20Vi-Fi%20scoring%5Cu2014a%20novel%20drug%20repurposing%20approach%20and%20simultaneously%20quantified%20antiviral%20and%20antifibrotic%20activities%20of%20the%20drugs%20based%20on%20their%20transcriptomic%20signatures.%20We%20revealed%20the%20strong%20dual%20antifibrotic%20and%20antiviral%20activity%20of%20EGFR%5C%2FErbB%20inhibitors.%20Before%20the%20in%20vitro%20validation%2C%20we%20have%20clustered%20277%20cell%20lines%20and%20revealed%20distinct%20COVID-19%20transcriptomic%20signatures%20of%20the%20cells%20with%20similar%20phenotypes%20that%20defines%20their%20suitability%20for%20COVID-19%20research.%20By%20ERK%20activity%20monitoring%20in%20living%20lung%20cells%2C%20we%20show%20that%20the%20drugs%20with%20predicted%20antifibrotic%20activity%20downregulate%20ERK%20in%20the%20host%20lung%20cells.%20Overall%2C%20our%20study%20provides%20novel%20insights%20on%20SARS-CoV-2%20dependence%20on%20EGFR%5C%2FERK%20signaling%20and%20demonstrates%20the%20utility%20of%20EGFR%5C%2FErbB%20inhibitors%20for%20COVID-19%20treatment.%22%2C%22date%22%3A%222021-05-27%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41598-021-90701-w%22%2C%22ISSN%22%3A%222045-2322%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41598-021-90701-w%22%2C%22deleted%22%3A1%2C%22collections%22%3A%5B%2243ZBJFKZ%22%5D%2C%22dateModified%22%3A%222021-05-27T16%3A09%3A46Z%22%7D%7D%5D%7D
Vagapova, E. R., Lebedev, T. D., & Prassolov, V. S. (2021). Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis. Scientific Reports, 11(1), 11234. https://doi.org/10.1038/s41598-021-90701-w Cite
